ESLA · Estrella Immunopharma, Inc. · Proposed Sales
$0.47
-0.01 (-1.47%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“As a result, management has determined that there is a substantial doubt about its ability to continue as a going concern. If the Company is unable to obtain adequate financing or generate significant revenue, it may be required to curtail or cease its operations.”View the 10-Q filed Aug 13, 2026
Market Cap
$20.92M
Shares
43.50M
Volume · Oct 2
14.49K
Avg daily vol (3M)
37.45K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.